Total
0
Shares
Skin Elements (ASX:SKN) - Executive Chairman, Peter Malone - The Market Herald
Executive Chairman, Peter Malone
Source: Business News
  • Skin Elements' (SKN) natural plant-based SE Formula has been proven 99.99 per cent effective against Feline coronavirus, a surrogate of COVID-19
  • The SE Formula is used within Skin Elements' Invisi Shield Natural hand sanitiser
  • Skin Elements originally teamed up with Holista CollTech to create this formula
  • The testing showed that the formula kills 99.99 per cent of the virus after exposure and was accepted under European testing standards
  • Skin Elements shares are currently suspended, with last trade at eight cents per share

Skin Elements' (SKN) natural plant-based SE Formula has been proven 99.99 per cent effective against Feline coronavirus, a surrogate of COVID-19. Both the Feline and COVID-19 coronaviruses are both members of the Coronaviridae family.

The testing shows the formula kills 99.99 per cent of the virus after exposure and was accepted under European testing standards. European testing standards are applied to ingredients used in the medical industry.

In April, the company finalised its Invisi Shield formula for the test. Skin Elements teamed up with Holista CollTech to create this plant-based formula.

The test was undertaken at Microbiological Solutions (MSL), a world-recognised, independent microbiology lavatory in the United Kingdom.

Skin Elements is a natural and organic skincare company that has international approvals to sell its Soléo Organics sunscreen and PapayaActivs therapeutic skincare products.

“These independent test results validate the efficacy of the SE Formula," Executive Chairman Peter Malone said.

"Our goal is to now pursue the development of all-natural organic, alcohol-free active products that offer a natural solution for protection and control against germs compared to existing products," he added.

Skin Elements shares are currently suspended, with last trade at eight cents per share.


Subscribe


SKN by the numbers
More From The Market Herald
OBJ (ASX:OBJ) - CEO, Paul Peros - The Market Herald

" OBJ (ASX:OBJ) to raise $4.5M for product development and licencing

Innovative wellness company OBJ (OBJ) is aiming to raise $4.5 million through an entitlement offer and placement for licencing, development and general workin…
Creso Pharma (ASX:CPH) - CEO & Co Founder, Dr Miri Halperin Wernli (left) and Chairman, Boaz Wachtel (right) - The Market Herald

" Creso Pharma (ASX:CPH) subsidiary receives follow-up order from Univo Pharmaceuticals

Creso Pharma’s (CPH) subsidiary, Mernova Medicinal, has received a US$625,690 (roughly A$901,830) purchase order from Univo Pharmaceuticals.
Holista Colltech (ASX:HCT) - Managing Director, Dr Rajen Manicka - The Market Herald

" Holista CollTech (ASX:HCT) misses the mark for hand sanitiser product

Holista CollTech (HCT) has downgraded its $3.8 million in expected sales from its hand sanitiser product, Natshield, due to COVID-19 and race riots.
Cellmid (ASX:CDY) - CEO, Maria Halasz (right) - The Market Herald

" Cellmid (ASX:CDY) signs distribution agreement for SARS-CoV-2 and ELISA’s

Cellmid (CDY) has signed a distribution agreement with Immunodiagnostics (IMD) for Enzyme Linked Immunosorbent Assays (ELISA’s) and SARS-CoV-2 tests in Australia and New